A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection

Saved in:

Bibliographic Details
Published in	Journal of hepatology Vol. 62; no. 5; pp. 1204 - 1206
Main Authors	Hassanein, Tarek, Sims, Karen D., Bennett, Michael, Gitlin, Norman, Lawitz, Eric, Nguyen, Tuan, Webster, Lynn, Younossi, Zobair, Schwartz, Howard, Thuluvath, Paul J., Zhou, Helen, Rege, Bhaskar, McPhee, Fiona, Zhou, Nannan, Wind-Rotolo, Megan, Chung, Ellen, Griffies, Amber, Grasela, Dennis M., Gardiner, David F.
Format	Journal Article
Language	English
Published	Netherlands Elsevier B.V 01.05.2015
Subjects	Adult Antiviral Agents - administration & dosage Antiviral Agents - adverse effects Benzazepines - administration & dosage Benzazepines - adverse effects Drug Monitoring Drug Resistance, Viral Enzyme Inhibitors - administration & dosage Enzyme Inhibitors - adverse effects Female Gastroenterology and Hepatology Hepacivirus - drug effects Hepacivirus - genetics Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology Humans Imidazoles - administration & dosage Imidazoles - adverse effects Indoles - administration & dosage Indoles - adverse effects Isoquinolines - administration & dosage Isoquinolines - adverse effects Male Middle Aged Sulfonamides - administration & dosage Sulfonamides - adverse effects Treatment Outcome
Online Access	Get full text
ISSN	0168-8278 1600-0641 1600-0641
DOI	10.1016/j.jhep.2014.12.025

More Information
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-Correspondence-3 content type line 23 ObjectType-Undefined-4
ISSN:	0168-8278 1600-0641 1600-0641
DOI:	10.1016/j.jhep.2014.12.025